Introduction
Carcinoma progression is associated with deposition of ECM that stiffens the local microenvironment [1, 2] . This tissue stiffening results in deposition of additional matrix proteins, initiating a positive feedback loop between cells and the evolving stroma [3] . Cells sense and respond to the stiffness of their environment via RhoA GTPase activation, which feeds back to increase cell contractility via activation of myosin light chain kinase [4] . These ECM-driven changes in cytoskeletal tension regulate motility in a cell-type specific manner [5] . In vitro, synthetic biomaterials have revealed that the type of material, stiffness, and biochemical surface modification alter the attachment and motility of cells [6, 7] . We therefore hypothesized that independently tuning stiffness, while altering integrin-binding sites in the presence of chemokinetic factors could reveal new mechanosensitive proteins that drive adhesion and motility in cancer cells.
Several mechanically responsive genes and proteins have been implicated in breast cancer metastasis [8] . For example, extracellular mechanical forces in the tumor microenvironment alter nuclear stiffness and gene expression [9] and activate adhesion proteins, including focal adhesion kinase (FAK) and talin [10] [11] [12] , leading to increased motility. One class of surface receptors, integrins, translate extracellular forces to downstream signaling cascades in a process called mechanotransduction. Increasing substrate stiffness increases integrin binding and clustering, which has implications for several pathways in breast cancer metastasis, including FAK and PI3K signaling [13, 14] . However, most cancer mechanobiology research has focused on collagen-and fibronectin-binding integrins. Integrins that bind to other ECM proteins, including laminin investigated here, have largely been neglected, despite the prevalence of laminins, such as laminin-111 and -511, in the ECM of many tumor types, including breast and prostate cancers [15] [16] [17] . In the breast cancer cell line, MDA-MB-231, laminin-511 enhances cell adhesion and migration [18] , while laminin-322 promotes cell survival [19] .
EGFR has recently emerged as mechanosensitive [20, 21] , and this process is critically relevant to cancer progression, given the known abundance of EGF in breast tumors [22] and frequent acquired resistance to EGFR inhibitors [23] . Residues on EGFR can be phosphorylated by α V β 3 integrin clustering [24] , so we postulated that there could be a role for integrins in facilitating EGFR mechanosensing [25] .
To uncover whether such a relationship exists, we created a biomaterial system to identify mechanoresponsive proteins working cooperatively downstream of EGFR phosphorylation and laminin-binding integrin engagement in breast cancer. Through a combination of transcriptomics, molecular biology, and quantification of cell adhesion and motility, we found that the intracellular protease calpain 2 is one of these links. Gene expression quantification revealed that both calpain 2 and integrin α 6 had an inverse relationship with ECM stiffness. Cell adhesion and motility experiments demonstrated that engagement of integrin α 6 resulted in mechanosensitive effects on adhesion and motility in the same manner as EGF stimulation. This suggested coordination of integrin α 6 with EGFR and that calpain 2 is downstream of both EGFR phosphorylation and integrin α 6 engagement. Further, this indicated that calpain 2 is a common signaling node in the cell that regulates motility and cell adhesion in a mechanosensitive manner. In sum, we highlight the utility of tunable biomaterials systems to uncover previously unrealized relationships between different classes of proteins in breast cancer mechanobiology.
Materials and Methods
Cell Culture. All cell culture reagents were purchased from Thermo Fisher Scientific Center. These cell lines preferentially metastasize to the bone (1833 BoM [26] ) brain (831 BrM2a [27] ) or lung (4175 LM2 [28] ). All cells were cultured in Dulbecco's modified eagle medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P/S) at 37°C and 5% CO 2 .
Synthesis of Poly(ethylene glycol)-phosphorylcholine (PEG-PC)
Gels. PEG-PC gels were formed as previously described [29] . For this application, a 17wt% solution of 2- diameter), allowed to swell for at least 48 hours and compression rheology was performed using an AR2000 (TA Instruments, New Castle, DE), as previously described [29] .
RNA-Seq. Total RNA was isolated using Gen Elute mammalian total RNA Miniprep kit (RTN70, Sigma Aldrich). The TruSeq stranded RNA LT kit (15032612, Illumina, San Diego, CA) was used to purify and fragment the mRNA, convert it to cDNA, and barcode and amplify the strands. Quality and length of the inserts was confirmed with an Agilent Genomics 2100 bioanalyzer, followed by single-end 75 bp reads on the MiSeq (Illumina) to generate a complete transcriptome from each sample. Transcripts were aligned to the hg19 human reference genome using the Tuxedo Suite pathway [30] [31] [32] [33] . Cufflinks was used to determine statistically significant differential expression of genes (p<0.05) [34] [35] [36] .
qRT-PCR. Total RNA was isolated from two biological replicates as previously described [37] . 50 ng cDNA was then amplified using 10 pmol specific primers (Table S1 ) and the Maxima Sybr green master mix (Thermo Fisher Scientific) on a Rotor-Gene Q thermocycler (Qiagen, Valencia, CA) as follows: 50°C for 2 minutes, 95°C for 10 minutes followed by 45 cycles at 95°C for 10 seconds, 58°C for 30 seconds, and 72°C for 30 seconds. Both β -actin and ribosomal protein S13
were included as reference genes to permit gene expression analysis using the 2 -ddCt method. Biosciences, San Jose, CA). Molecular Probes secondary antibodies were used at a 1:500 dilution (goat anti-mouse 555 (A21422) and goat anti-rabbit 647 (A21244) or goat anti-rabbit 488 (A11008), Thermo Fisher Scientific). Cells were then treated with DAPI at a 1:5,000 dilution for 5 minutes, and washed in PBS prior to imaging of 2 biological replicates on a Zeiss Cell Observer Spinning Disk (Carl Zeiss AG).
Matrix Decellularization. Cells were cultured on PEG-PC gels of 1, 4, 8, and 41 kPa for 24 hours or 6 days, and the resulting matrix created by the cells was visualized by adapting a previously published protocol [38] . Briefly, cells were washed with warm PBS, then lysed with 500µL warm extraction buffer (PBS with 0.5% Triton-X with 20 mM ammonium hydroxide) for 10 minutes at room temperature. 1 mL of PBS was added and the gels were stored overnight at 4°C before staining as described above. Membranes were imaged on the Odyssey CLx (Licor).
Protein and Phospho
2 biological replicates of lysates were collected during cell adhesion at time 0, at 5 minutes, and at 24 hours. At 5 minutes, the adhered fraction was lysed off the surface, while suspended cells were pelleted, then lysis buffer was added. These 2 fractions were combined for analysis.
Phospho-protein levels were quantified with the MAGPIX system (Luminex, Austin, Texas)
with MILLIPLEX MAP Multi-Pathway Magnetic Bead 9-Plex -Cell Signaling Multiplex Assay 
Results

Cells Maximize Expression of Integrin α 6 and Extracellular Laminin on Soft Substrates
To identify ECM and integrin-associated genes involved in breast cancer mechanosensing, we performed whole transcriptome sequencing (RNA-Seq) on MDA-MB-231 cells cultured on collagen 1-functionalized PEG-PC hydrogels ranging in stiffness from 1 to 41 kPa for either 24 hours or 6 days (Fig. S1a ). The stiffness range chosen spans that of several tissues in the body where breast cancer metastasizes (1 kPa-brain [39] , 4 kPa-bone marrow [40] , 8 kPa-lung [41] ), as well as a supra-physiological stiffness (41 kPa) that approximates extremely stiff breast tumors [42] and a tissue culture polystyrene (TCPS) control ( Fig. S1 ).
Because the ECM is known to regulate the ability of cancer cells to migrate and metastasize, we focused our in-depth analysis of this RNA-Seq data set on genes that regulate interaction with the ECM. We found that the expression of integrins, other focal adhesion complex genes, and genes downstream of EGFR phosphorylation became sensitive to stiffness over time ( Fig. 1a-b , Fig. S1b ). Short-term (24 hour) decreases in expression were clear in integrin α 6, calpain 2, and integrin β 4 ( Fig. 1a ). However, integrin β 4 expression was 3-fold higher on gels than on TCPS after 6 days of culture ( Fig. 1b ), which we confirmed at the protein level ( Fig. S2a ). This implies a switch in dimer pairs, as integrin α 6 preferentially dimerizes with integrin β 4 over integrin β 1 [43] . This is an important finding, as α 6 β 4 is known to be important in cancer cell motility and invasion [44] . We compared the day 6 gene expression data from Figure 1b to that at 24 hours from Figure 1a and found that the expression of this subset of genes was generally higher at day 6 ( Fig. S1b ), suggesting a time-dependent mechanosensing event related to this set of integrins, focal adhesion proteins, and EGFR.
Given that integrin α 6 β 4 is laminin-binding, and that we saw mechanosensitive changes in α 6 gene and protein expression ( Fig. S2b ), we hypothesized that we could tune integrin α 6 mechanosensing on these surfaces by supplementing the collagen-functionalized hydrogel surfaces with β 1 -chain-containing laminins. On soft gels, integrin α 6 expression was higher at 24
hours with added laminin compared to collagen 1 only, and it was also high after 6 days of culture, even in the absence of supplemented laminin (Fig. 1c, Fig. S2c ). This mechanosensitivity appears to be specific to integrin α 6 as other laminin-binding integrins (e.g. integrin α 3 ) did not follow this trend ( Fig. S2d-e ).
As we noted this integrin α 6 effect when we supplied only collagen 1, we hypothesized that cells might be producing their own laminin to support integrin α 6 binding at the longer culture times. Immunofluorescent staining revealed that laminin, but not collagen 1 (Fig. 1d ) or fibronectin ( Fig. S3a) , was upregulated on the softer gels at 6 days. We separately confirmed that differential staining was not due to ECM proteins crosslinked to the gels or from serum (Fig.   S3b ). Cultures that were decellularized after 6 days showed the highest amount of extracellular laminin on the softest, 1 kPa gels (Fig. 1d) , concordant with the increase in integrin α 6 expression
in Figure 1c .
To understand the impact of laminin and integrin α 6 expression on cell phenotype, we quantified cell spreading during initial adhesion to the hydrogel surfaces. We found cells spread to similar extents across the 4 stiffnesses examined here when only collagen 1 was present ( Fig.   1e ). However, when laminin (0.5µg/cm 2 ) was added to the collagen (10µg/cm 2 ) on the gel surfaces, cell spreading was mechanosensitive (Fig. 1f ). We attempted to remove collagen from the experiment completely, but found that cells did not adhere to laminin-only hydrogels (data not shown). This was not surprising given the documented role of laminin being somewhat anti-adhesive [45] . In sum, cells upregulate integrin α 6 expression on soft substrates, which correlates with secretion of extracellular laminin. This coordination appears to take several days, but the mechanosensitivity effect on cell spreading can be accelerated by adding β 1 -chain-containing laminin to the culture substrata.
Cell Response to EGF Stimulation Mirrors Mechanosensing on Laminin
Given the prevalence of EGF in the tumor microenvironment and its known role in promoting cancer cell motility, we posited that the mechanosensitive expression of EGFR alongside the laminin-binding integrin α 6 implied that they mechanotransduce under a related pathway. Similar to previous reports, we found that MDA-MB-231 cells spread to a smaller area on hydrogels upon addition of EGF prior to and during adhesion [37] , achieving a similar size to cells on soft, laminin-coated gels without EGF ( Fig. 2a ). EGFR is known to associate with the α 6 β 4 integrin heterodimer to enhance clustering and response to EGF [46] , and in agreement with this report, we found that the addition of EGF increased the association of integrin α 6 with EGFR in our system (Fig. S4a ). We separately analyzed the protein expression of integrin α 6 and EGFR in variants of the MDA-MB-231 cell line selected for their ability to metastasize specifically to the brain, bone, and lung [26] [27] [28] . The brain tropic cells, which metastasize to the softest of these sites, have the highest expression of both integrin α 6 and EGFR (Fig. S4b) .
To test the necessity of integrin α 6 in the observed response to EGF, we generated a stable shRNA knockdown cell line (shITGA6, Fig. S4c-e ). We quantified adhesion of the shITGA6 cells to collagen-functionalized gels, and found that they spread to a larger area during adhesion with EGF stimulation, compared to cells transfected with the scramble control (shSCR), suggesting a role for integrin α 6 during EGF response on collagen (Fig. 2b) . Even though there was no laminin present, others have demonstrated a role for integrin α 6 in facilitating growth factor response, independent of laminin binding [47] . Combined with our data, this implicates a mechanosensitive role for integrin α 6 during EGFR signaling (Fig 2b) .
EGF Overwhelms Laminin-Based Mechanosensing and Maximizes Cell Motility on Soft
Substrates
To further explore the relationship between integrin α 6 and EGFR signaling during adhesion, we functionalized hydrogels with collagen 1 and laminin, and treated the cells with lapatinib, a dual tyrosine kinase inhibitor against EGFR and HER2. This approach allowed cells to engage integrin α 6 during adhesion, while preventing EGFR signaling by obstructing ATPbinding on the intracellular domain of EGFR and HER2. When pretreated with lapatinib, we found that cells adhering on 41 kPa hydrogels spread to a significantly larger area than cells on 1 kPa hydrogels (Fig. 2c ). This result mimics the adhesion we observed of cells on laminin without supplemented EGF or lapatinib (Fig. 1f ). Further, when we supplemented cells with soluble EGF on the surfaces functionalized with collagen 1 and laminin, cells on both 1 and 41 kPa spread to a smaller area (Fig. 2d ). This EGF-induced reduction in spreading is similar to our observations of cells on collagen 1 only in the presence of soluble EGF ( Fig. 2a ). Together, these data suggest that, even in the presence of laminin, adhesion signaling through EGFR dominates, but in the absence of exogenous EGF, signaling via mechanosensitive integrin α 6 controls cell spreading during adhesion.
We observed that sEGF caused rapid internalization of EGFR, within 10 minutes of administration ( Fig. S4f ). To promote sustained EGFR signaling to examine its relationship with integrin α 6 [46] , we covalently linked both collagen 1 and EGF to the surface of the hydrogels.
This EGF presentation minimized EGFR internalization ( Fig. S4f ) and localized both pEGFR(Y1068) and total EGFR to regions of vinculin staining ( Fig. 2e, Fig. S5a ). EGFR receptor internalization was required for EGF to moderate adhesion, as only cells supplemented with soluble EGF showed measurable differences in cell area after 40 minutes (Fig. 2f ). However, bound EGF had a measurable effect on cell motility (Fig. 2g) . First, we observed a biphasic trend in cell speed with respect to stiffness. This phenomenon has previously been described in many cell types, including smooth muscle cells [7] and glioma cells in both 2D [48] and 3D [49] . In this migration study, only collagen 1 was present, suggesting that collagen-binding integrins contributed to this mechanosensitive motility after 24 hours [50] . Our data agree with literature reports demonstrating that cells seeded on collagen 1 exhibit mechanosensitive motility [51] , but do not differ in adherent area between 1 and 30 kPa [52] . The addition of bound EGF increased cell motility across the stiffness range tested here (Fig. 2g) , and shifted the biphasic curve to softer substrates, requiring us to expand the mechanical range of the hydrogels to capture the full curve ( Fig. S5b ) [29] . We also observed a role for integrin α 6 in regulating this EGF-dependent motility, as shITGA6 cells were less responsive to EGF than the control (Fig. 2g ). The scramble control cells, which peaked at 34 µ m/hr on 1 kPa gels, were more responsive to EGF than the shITGA6 cells ( Fig. S5c) . Interestingly, shITGA6 cells don't respond to changes in stiffness from 1 to 18 kPa, either in control media, or in response to soluble EGF (Fig. S5d ). Together, this data suggests that the addition of EGF alters mechanosensitive motility and that the MDA-MB-231 breast cancer cells are dependent on integrin α 6 for this response. Inspired by the trends observed in the RNA-seq data (Fig. S1 ), we clustered our PCR data from the 24 hour time point, which uncovered that ITGA6 and EGFR expression clustered with the intracellular protease CAPN2 (Fig. 3a) . Calpain 2, which has been implicated in focal adhesion formation and disassembly, is thought to play an important role in breast cancer cell motility and metastasis [53] . Because calpain 2 is activated by ERK [54] , we performed phosphoanalysis of multiple kinases in integrin-and EGFR-dependent pathways (Fig. S6a) . Steady-state phosphorylation of EGFR, MEK, and ERK increased on stiffer surfaces, as previously demonstrated [20, 55, 56] (Fig. S6b) . However, we observed the opposite trend with the activation of calpain 2 (Fig. S6c ).
Calpain 2 is Downstream of both EGFR and Integrin
We observed higher calpain 2 activity (autolysis) during adhesion to the soft hydrogels compared to tissue culture plastic (Fig. 3b ). Although repeated multiple times, this trend was not statistically significant. There was a functional role for calpain 2 during mechanosensing on the gels, however, as a pharmacological inhibitor to either calpain 2 or ERK had no effect on cell spreading on 1 kPa gels, but resulted in significantly larger cells on 41 kPa gels ( Fig. 3c-d) . In parallel, to provide evidence of the necessity of calpain 2 in responding to EGF stimulation, we generated a CAPN2 knockdown cell line (Fig. S7a-c) , and observed that those cells were less responsive to EGF than the scramble control cells during adhesion, independent of stiffness ( Fig.   S7d ). Further, calpain 2 inhibition was sufficient to limit cell response to soluble EGF using a pharmacological inhibitor (Fig. S7e) . However, when we limited calpain 2 activity in integrin α 6 knockdown cells, the effect of larger cells during adhesion was exaggerated (Fig. S7e) .
We further hypothesized that altering calpain 2 activity could disturb the typical biphasic relationship between cell migration speed and matrix stiffness given its known role in mediating focal adhesion turnover [54] . Inhibiting ERK activity entirely eliminated the durokinesis effect, and calpain 2 inhibition shifted the migration curve maximum to lower stiffnesses (Fig. 3e ). The limiting step during motility on stiff surfaces is retraction of the rear edge [57] , and here we demonstrate that inhibiting calpain 2 reduces cell migration on stiffer substrates, likely because of this reduced ability to turn over adhesions. We then compared migration speeds of the integrin α 6 knockdown and scramble control cells from figure 2, in response to the calpain 2 inhibitor (Fig.   S5d ). We found that the scramble control cells responded to the inhibitor similarly to the parental cells, although the addition of soluble EGF was able to partially overcome that inhibition.
However, the shITGA6 cells exhibited slower migration at 18 kPa even in the control media, so the calpain 2 inhibitor had no additional effect (Fig. S5d ).
After 24 hours of culture on PEG-PC gels with collagen 1 or collagen 1 and bound EGF, cells adopted a normal morphology with no noticeable protrusions (Fig. S7f ). However, in the presence of lapatinib, ERK inhibitor, or calpain 2 inhibitor, we observed that cells left behind long, stable protrusions at the rear of the cell (Fig. S7f) , indicative of their inability to release adhesion sites [58] . There were minimal observable differences in morphology as a function of stiffness, regardless of the pharmacological treatment applied. This suggests that at these concentrations, the inhibitors impact focal adhesion turnover enough to functionally alter motility with marginal impacts on morphology at these stiffnesses.
While we demonstrated earlier that integrin α 6 is necessary for both mechanosensitive and EGFR-mediated adhesion, this data suggests that EGFR activates calpain 2 to regulate mechanosensitive motility in breast cancer cells. To some extent on collagen-functionalized hydrogels, and particularly on plastic, calpain 2 activity was low, and EGF stimulation increased calpain 2 activity on the hydrogels (Fig. 3f ). Finally, when we supplemented the gels with laminin, calpain 2 activity was maximized on both stiffness gels, suggesting an additional role for integrin α 6 engagement to activate calpain 2. Interestingly, when integrin α 6 is knocked down in a stable manner, the cells still exhibit calpain 2 activity, suggesting that the cells might be compensating for the lack of integrin α 6 signaling via another mechanism, not explored here (Fig.   S7g ). Together, these data suggest that the mechanosensitive receptors integrin α 6 and EGFR both activate calpain 2 to facilitate stiffness-dependent adhesion and migration.
Discussion
This work demonstrates integrin α 6 and calpain 2 as mechanosensitive proteins important for stiffness-driven breast cancer cell adhesion and migration (Fig. 4a ). The mechanosensitivity of calpain 2 is a new finding, as well as the role of integrin α 6 in EGFR signaling that facilitates cell adhesion (Fig. 4b) . EGF is known to enhance breast cancer cell adhesion and motility, and here we demonstrate that mechanosensitive integrin α 6 and EGFR both signal through calpain 2. We also contribute that in the absence of EGF stimulation, integrin α 6 and calpain 2 regulate stiffnessdependent adhesion and motility (Fig. 4b ).
We focused this study on breast cancer cells because of the important roles for ECM binding and stiffness in metastasis. Cancer metastasis begins with individual or collective groups of cells migrating away from the primary tumor site [59] [60] [61] . This motility is driven in part by cell-ECM adhesion via integrins and the creation and turnover of focal adhesions, both of which are known to be sensitive to the stiffness of the surrounding ECM [62] . Integrins have well documented responses to changes in the microenvironment stiffness. As two examples, the expression of integrins α 2 , α 3 , and β 1 is higher in mouse mammary epithelial cells cultured on TCPS compared to cells on a soft basement membrane-like matrix [50] , and integrin α 5 expression was found to increase 5-fold on a 10 kPa stiffness compared to 1 kPa in cancer cells [17] and over a similar range in fibroblasts [63] . Most of this work has focused on collagen-and fibronectin-binding integrins, with the exception of one paper on integrin α 6 in fibroblasts, where expression increased with stiffness, resulting in increased invasion [64] . We demonstrate here the mechanosensitivity of integrin α 6 in breast cancer cells, and the downstream regulation of cell adhesion, migration, and response to EGF (Fig. 1c, Fig. 2b ). Integrin α 6 is a laminin-binding subunit, and so many of the stiffness-sensitive phenotypes we observed either required, or were exaggerated by, addition of laminin to the culture substrate. However, cells exhibited mechanosensitive behavior on collagen alone when cells were on hydrogels for longer times. For example, we observed a biphasic relationship in migration speeds on collagen 1 only ( Fig. 3e ).
We present data that on soft surfaces, cells produce extracellular laminin and engage integrin α 6 in these instances, and that knocking down integrin α 6 expression limited response to EGF (Fig. 2g ).
Previous work has established the role of integrin α 6 in key aspects of the metastatic cascade. Low integrin α 6 expression inhibits the migration and proliferation necessary for establishing metastases at distant secondary sites [65] . Additionally, integrin α 6 expression can protect cells from radiotherapy treatment both through PI3K and MAPK activity [66] . In a cohort of 80 patients, integrin β 4 was co-expressed with integrin α 6 and laminin in primary tumors, and co-expression of α 6 β 4 with laminin production was significantly correlated with breast cancer relapse and death [43, 67] . This is further supported by other work in breast cancer, that elucidates the role of laminin-511 in cell adhesion and migration [18] , which are key phenomena in the metastatic cascade. Our data demonstrate that this is a mechanoresponsive effect, as the most laminin is secreted by the breast cancer cells on the softest substrate ( Fig. 1d ). Interestingly, this phenomenon is not maintained in other secreted ECM proteins, such as collagen 1 (Fig. 1d ) or fibronectin ( Fig. S3a ), suggesting a key role for integrin α 6 binding to laminin on soft surfaces. This is possibly mediated through the mechanically responsive transcription factor, TAZ [68] , which has been shown to regulate laminin production [69] . Here we found that both integrin β 4 expression and laminin production increased after 6 days of culture on soft gels (Fig. 1b, Fig. 1d ),
where EGF enhances migration in an integrin α 6 -dependent manner (Fig. 2g ).
We further observed that during cell adhesion, integrin α 6 engagement with laminin decreased cell size and facilitated adhesion similarly to EGF ( Fig. 2a-b ). Smaller cells can be correlated with a cancer stem cell and invasive phenotype [70] , and our work suggests integrinmediated mechanotransduction contributes to that behavior. The α 6 β 4 integrin dimer associates with EGFR [46] , and we observed that integrin α 6 engagement increased the sensitivity to EGF ( Fig. 2b) . Further, our data agrees with other work, which has demonstrated that the integrin dimer α 6 β 4 plays an important role in cell response to growth factors, even in the absence of laminin [47] . We also observed that integrin α 6 adhesion shows a similar phenotypic response on soft hydrogels as EGF stimulation.
Downstream of integrin α 6 engagement and EGFR phosphorylation, cells activate calpain 2, which facilitates focal adhesion turnover, and therefore, motility ( Fig. 3e-f ). EGFR phosphorylation is necessary for mechanosensing [21] and activity in downstream effectors, including MEK, ERK, and calpain 2 at the cell membrane [71, 72] , to cleave focal adhesion proteins vinculin, talin, paxillin, and FAK [73, 74] . Additionally, recent work has demonstrated that calpains are recruited to protrusions containing integrin β 4 [75] . During adhesion, we saw that calpain 2 activity was higher in cells on the hydrogels compared to TCPS, which was consistent with RNA levels (Fig. 1a-b, Fig. S6c ). Calpain 2 inhibition during adhesion resulted in larger, less motile cells on stiff substrates. The opposite trend in adhesion was observed when activating this pathway, as cells spread to a smaller area at both 1 and 41 kPa in the presence of soluble EGF 2 0 ( Fig. 2a ). Together, these data suggest that EGFR phosphorylation could be a stronger activator of calpain 2 than stiffness. Previous work has shown that calpain 2 has a significant correlation with an epithelial-to-mesenchymal transition [76] and lymphatic or vascular invasion, where patients with basal-like tumors and high calpain 2 expression had a significantly worse prognosis [77] .
Others have also found that this is an isoform-specific effect, as calpain 2, but not calpain 1, was upregulated in gastric cancer compared to healthy tissue [78] . Our work demonstrates a mechanosensitive role for calpain 2, downstream of both integrin α 6 and EGF, providing further evidence for its potential as a druggable target for metastatic breast cancer.
Conclusions
Mechanical forces have long been thought to play a role in tumor progression, and here we shed new light on two mechanoresponsive proteins that influence breast cancer cell motility:
integrin α 6 and calpain 2. First, enhanced integrin α 6 expression on soft substrates is associated with increased adhesion and laminin secretion. Second, we find that both integrin α 6 and EGFR activate calpain 2 in a mechanosensitive manner, which mediates cleavage of focal adhesion proteins necessary for motility. Others have suggested targeting calpains to inhibit cancer cell invasion [79] , and here we provide a mechanosensitive role of calpain 2 using tunable hydrogel substrates.
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